Checked.be
Active
BE 0675.991.020Private limited company
Perio
Mechelsesteenweg 5 ·2220 Heist-op-den-Berg, Belgium· 9 yrs active
Sector: Human health
(86230)
Conclusion
The computed 12-month bankruptcy probability of Perio is 0.1% (very low). The 2024 annual accounts show equity of €309k and a net result of €100k. Equity is growing by ~11.2% per year across the filed fiscal years. Its solvency ranks better than 38% of 382 sector peers (fiscal year 2024). The company has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 7 annual accounts.
Key figures
| Equity | €309k |
| Net result | €100k |
| Staff (FTE) | 15 |
| Better than sector | 38% |
Snowflake analysis
82
/ 100
Exceptional profile, strong across almost every axis.
Health
75
Profitability
100
Solvency
56
Growth
78
Stability
100
Bankruptcy probability (12 mo)
0.1%
Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Multiple establishment units
+
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2017, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
No administrative flags
Health barometer
75
/ 100
Excellent
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.
Financial overview
Annual accounts filed on 07-08-2025 with the NBB · fiscal year 2024 · verkort
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Equity: growth of ~11.2%/year over 7 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (abbreviated schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 32.8% | 50.3% | |
| Net result | €100k | €72k | |
| Equity | €309k | €127k | |
| Gross operating margin | €961k | €179k | |
| Staff costs | €667k | €134k |
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
€292k
+6.1%
+121% vs sector
€100k
-5.1%
+80% vs sector
€236k
-2.3%
+133% vs sector
€940k
-14.8%
+23% vs sector
€309k
-0.1%
-48% vs sector
€69k
-25.8%
-83% vs sector
15
+18.1%
far above sector median
€667k
+13.3%
far above sector median
€49k
+111.8%
+111% vs sector
€100k
0.0%
+31% vs sector
€631k
-20.5%
+241% vs sector
€331k
-3.1%
+107% vs sector
€300k
-30.7%
far above sector median
1.21
-5.0%
-65% vs sector
1.04
-9.8%
-70% vs sector
32.8%
+17.2%
-56% vs sector
2.05
-20.4%
far above sector median
32.3%
-4.9%
+207% vs sector
10.6%
+11.4%
+3% vs sector
35.14
+39.2%
+59% vs sector
Figures by fiscal year
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €292k |
| Net profit | €100k |
| Cash flow | €236k |
| Staff costs | €667k |
| Income taxes | €49k |
| Dividends | €100k |
| Total assets | €940k |
| Equity | €309k |
| Debt | €631k |
| of which ≤ 1y | €331k |
| of which > 1y | €300k |
| Working capital | €69k |
| Employees (FTE) | 15.0 |
Ratios (computed)
| 2024 | |
|---|---|
| Current ratio | 1.21 |
| Quick ratio | 1.04 |
| Working capital ratio | 7.3% |
| Solvency | 32.8% |
| Debt / equity | 2.05 |
| Long-term debt ratio | 0.97 |
| Interest coverage | 35.14 |
| Gross margin | - |
| Net margin | - |
| ROA | 10.6% |
| ROE | 32.3% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €940k |
| Fixed assets | 21/28 | €540k |
| Intangible fixed assets | 21 | €114k |
| Tangible fixed assets | 22/27 | €408k |
| Financial fixed assets | 28 | €19k |
| Current assets | 29/58 | €400k |
| Stocks & contracts in progress | 3 | €55k |
| Amounts receivable within one year | 40/41 | €34k |
| Investments | 50/53 | €100k |
| Cash & bank | 54/58 | €164k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €940k |
| Equity | 10/15 | €309k |
| Contributions / capital | 10/11 | €19k |
| Reserves | 13 | €290k |
| Amounts payable | 17/49 | €631k |
| Amounts payable after one year | 17 | €300k |
| Amounts payable within one year | 42/48 | €331k |
| Trade debts payable within one year | 44 | €18k |
| Income statement | ||
| Gross operating margin | 9900 | €961k |
| Operating result | 9901 | €155k |
| Financial income | 75 | €2k |
| Financial charges | 65 | €8k |
| Result before taxes | 9903 | €149k |
| Income taxes | 67/77 | €49k |
| Net result for the period | 9904 | €100k |
| Result to be appropriated | 9905 | €100k |
You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan.
See plans →
Ratios computed by Checked.
Legal Structure
| NACE primary | Human health(86230) |
| Legal form | Private limited company(610) |
| Incorporation | 24-05-2017 |
| Status | Active |
| Postal code | 2220 |
Establishment units
Perio
since 20172.266.420.638
Mechelsesteenweg 1, 2220 Heist-op-den-Berg
since 20212.313.452.572
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12322I0442/00Y003 | Flanders | 3,308 m² | 1 · 2,217 m² | - |
| 12322I0373/00Z000 | Flanders | 380 m² | 1 · 280 m² | 14.4 m · 4 fl. |
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
2025
07-08-2025
NBB filing
Annual accounts filed
2024
30-08-2024
NBB filing
Annual accounts filed
31-01-2024
State Gazette act
Capital & shares
2023
28-07-2023
NBB filing
Annual accounts filed
2022
25-07-2022
NBB filing
Annual accounts filed
2021
22-07-2021
NBB filing
Annual accounts filed
2020
31-08-2020
NBB filing
Annual accounts filed
2019
31-07-2019
NBB filing
Annual accounts filed
Belgisch Staatsblad, acts
Capital history · 1
31-01-2024
Capital change
All acts · 1
updated 2 years ago
2024
31-01-2024 Transaction in capital or shares
Notary:
Stephane Van Roosbroeck · Boechout
Technical details
{
"events": [
{
"kind": "vzw_capital_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "suppress"
}
],
"notary": {
"name": "Stephane Van Roosbroeck",
"firm_city": null,
"firm_name": null,
"office_city": "Boechout",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-01-31",
"filing_date": "2024-01-29",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-01-11",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": "2024-01-11"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0675.991.020",
"name_full": "Perio",
"legal_form": "Co\u00F6peratieve vennootschap met beperkte aansprakelijkheid",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"plan financier",
"bankattest",
"verslag bedrijfsrevisor"
],
"shareholders_after": [],
"share_classes_after": []
}Credit advice
AI due-diligence brief
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.
Company registry (CBE)
Activities
Tandartspraktijken86230Activiteiten van tandartspraktijken86230
Primary activity highlighted.
Names & trade names
| Legal nameNL | Perio |
Registered office
Mechelsesteenweg 5
2220 Heist-op-den-Berg, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies
ODENTA
BE 0443.478.852 · Menen
SPOORMANS MARC
BE 0447.130.309 · Ravels
Clinique dentaire des Arts
BE 0423.183.581 · Brussel
RETETI
BE 0436.377.165 · Sint-Katelijne-Waver
VERCAIGNE SUZY
BE 0476.536.254 · Retie